Napier Park Global Capital (US)’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Napier Park Global Capital (US)’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-17,715	Closed	-$3.06M	–	61
2015 Q1	$3.06M	Buy	+17,715	New	+$2.6M	1.03%	20
2014 Q4	–	Sell	-5,220	Closed	-$816K	–	72
2014 Q3	$816K	Buy	+5,220	New	+$757K	0.28%	41

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Napier Park Global Capital (US)'s SLXP Position: Q2 2015 in Review

Napier Park Global Capital (US) sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 17,715 shares — an estimated $3.06M sold.

Napier Park Global Capital (US) first reported a position in SLXP in Q3 2014 and held it in 2 quarters. The position peaked at $3.06M in Q1 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

Napier Park Global Capital (US) reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
Napier Park Global Capital (US) sold 17,715 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $3.06M.
Napier Park Global Capital (US) first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q3 2014 and held it in 2 quarters.
Napier Park Global Capital (US)'s SALIX PHARMACEUTICALS LTD DEL position peaked at $3.06M in Q1 2015.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Napier Park Global Capital (US)'s 13F filing for Q2 2015, filed 7 Aug 2015.